Wen-Yang Hu

Inhibiting myosin light chain kinase retards the growth of mammary and prostate cancer cells.

Increased myosin light chain kinase expression in hypertension: Regulation by serum response factor via an insertion mutation in the promoter.

Involvement of Ras-regulated myosin light chain phosphorylation in the captopril effects in spontaneously hypertensive rats.

Regulation of myosin light chain kinase expression by angiotensin II in hypertension.

The role of Wnt5a in prostate gland development.

Estrogen-initiated transformation of prostate epithelium derived from normal human prostate stem-progenitor cells.

Estrogen action and prostate cancer.

Actions of estrogens and endocrine disrupting chemicals on human prostate stem/progenitor cells and prostate cancer risk.

Tumor stiffness is unrelated to myosin light chain phosphorylation in cancer cells.

Bisphenol A promotes human prostate stem-progenitor cell self-renewal and increases in vivo carcinogenesis in human prostate epithelium.

Stem Cells as Hormone Targets That Lead to Increased Cancer Susceptibility.

Exposure of Human Prostaspheres to Bisphenol A Epigenetically Regulates SNORD Family Noncoding RNAs via Histone Modification.

Arsenic Induces p62 Expression to Form a Positive Feedback Loop with Nrf2 in Human Epidermal Keratinocytes: Implications for Preventing Arsenic-Induced Skin Cancer.

Isolation and functional interrogation of adult human prostate epithelial stem cells at single cell resolution.

Prostate Cancer Risk and DNA Methylation Signatures in Aging Rats following Developmental BPA Exposure: A Dose-Response Analysis.

Sonic hedgehog regulation of human rhabdosphincter muscle:Potential implications for treatment of stress urinary incontinence.

WNT2 is necessary for normal prostate gland cyto-differentiation and modulates prostate growth in an FGF10 dependent manner.

Evaluation of Bisphenol A (BPA) Exposures on Prostate Stem Cell Homeostasis and Prostate Cancer Risk in the NCTR-Sprague-Dawley Rat: An NIEHS/FDA CLARITY-BPA Consortium Study.

Targeting prostate cancer cells with enzalutamide-HDAC inhibitor hybrid drug 2-75.

Differential Actions of Estrogen Receptor α and β via Nongenomic Signaling in Human Prostate Stem and Progenitor Cells.

The role of WNT10B in normal prostate gland development and prostate cancer.